KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) EBIT (2016 - 2025)

Insulet's EBIT history spans 16 years, with the latest figure at $146.3 million for Q4 2025.

  • For Q4 2025, EBIT rose 33.85% year-over-year to $146.3 million; the TTM value through Dec 2025 reached $473.9 million, up 53.47%, while the annual FY2025 figure was $473.8 million, 53.38% up from the prior year.
  • EBIT reached $146.3 million in Q4 2025 per PODD's latest filing, up from $117.7 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $146.3 million in Q4 2025 to a low of -$26.7 million in Q2 2022.
  • Average EBIT over 5 years is $58.3 million, with a median of $52.1 million recorded in 2021.
  • Peak YoY movement for EBIT: plummeted 201.52% in 2022, then surged 1789.66% in 2023.
  • A 5-year view of EBIT shows it stood at $49.7 million in 2021, then tumbled by 52.72% to $23.5 million in 2022, then surged by 353.19% to $106.5 million in 2023, then increased by 2.63% to $109.3 million in 2024, then skyrocketed by 33.85% to $146.3 million in 2025.
  • Per Business Quant, the three most recent readings for PODD's EBIT are $146.3 million (Q4 2025), $117.7 million (Q3 2025), and $121.1 million (Q2 2025).